1. Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs
   Matteo Canale et al, 2020, Journal of Clinical Medicine CrossRef
2. Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma
   Rodrigo de Oliveira Cavagna et al, 2023, Pathobiology CrossRef
3. A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity
   Carmela Gallo et al, 2020, Marine Drugs CrossRef
4. PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
   Ali Alqahtani et al, 2019, Cancers CrossRef
5. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma
   Thinh T. Nguyen et al, 2022, Genome Medicine CrossRef
6. Stratification of Patients With Stage IB NSCLC Based on the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging Manual
   Lei-Lei Wu et al, 2020, Frontiers in Oncology CrossRef
7. A Local Outlier Factor-Based Detection of Copy Number Variations From NGS Data
   Xiguo Yuan et al, 2021, IEEE/ACM Transactions on Computational Biology and Bioinformatics CrossRef
8. Malfeasance of KRAS mutations in carcinogenesis
   Rupal Tripathi et al, 2021, Clinical and Experimental Medicine CrossRef
9. Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
   Bo Peng et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
10. Genomic features of lung cancer patients in Indonesia’s national cancer center
    Arif Riswahyudi Hanafi et al, 2024, BMC Pulmonary Medicine CrossRef
11. Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
    Talip Zengin et al, 2021, Journal of Personalized Medicine CrossRef
12. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation
    Ângela Carvalho et al, 2021, Cancers CrossRef